Sitagliptin, metformin (as HCl) ext-rel; 50mg/500mg, 50mg/1000mg, 100mg/1000mg; tabs. Individualize. Swallow whole. Take once daily with a meal, preferably in the evening. Not currently treated with ...

FDA Approves JANUMETâ„¢ For Type 2 Diabetes, Offering Powerful Glucose Control Of A DPP-4 Inhibitor And Metformin In A Single Tablet Merck & Co., Inc. announced today that the U.S. Food and Drug ...

Lupin has received tentative approval from the Food and Drug Administration for sitagliptin and metformin hydrochloride tablets, 50 mg/500 mg and 50 mg/1000 mg, which is a generic of Merck Sharp & ...

Merck announced that the FDA has approved Janumet XR (sitagliptin/metformin HCl extended-release tablets) for the treatment of type 2 diabetes. Janumet XR is indicated as an adjunct to diet and ...

Merck announced that Janumet—a single-tablet combination of sitagliptin (Januvia) and metformin—has cleared the FDA. The new combination is to be used as an adjunct to diet and exercise for improved ...